The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
This Article
Right arrow Full Text (PDF, 495K)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muckenfuss, R. S.
Right arrow Articles by Rivers, T. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Muckenfuss, R. S.
Right arrow Articles by Rivers, T. M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
The Journal of Experimental Medicine, Vol 51, 149-159, Copyright, 1930, by The Rockefeller Institute for Medical Research New York

ARTICLE

SURVIVAL OF VACCINE VIRUS SEPARATED FROM LIVING HOST CELLS BY COLLODION MEMBRANES

R. S. Muckenfuss M.D.1 and T. M. Rivers M.D.1

1 From the Hospital of The Rockefeller Institute for Medical Research

Vaccine virus, suspended in a mixture of serum and Tyrode's solution and separated by collodion membranes from a suspension of living kidney cells in serum and Tyrode's solution, remained active at 37°C. for a longer period of time than did vaccine virus incubated only in a mixture of serum and Tyrode solution.

Submitted on October 28, 1929


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS